NDC codes

FDA NDC Directory
Product NDC (as listed)16571-126Labeler and product segments. Claims need a package NDC.
Product NDC at billing width16571-0126Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
16571-126-011657101260116571012601100 TABLET, FILM COATED in 1 BOTTLE (16571-126-01)Marketed from Jan 24, 2020
16571-126-06165710126061657101260660 TABLET, FILM COATED in 1 BOTTLE (16571-126-06)Marketed from Jan 24, 2020
16571-126-501657101265016571012650500 TABLET, FILM COATED in 1 BOTTLE (16571-126-50)Marketed from Jan 24, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Tolterodine Tartrate
Generic name (nonproprietary)
tolterodine tartrate
Active ingredients
Tolterodine tartrate — 1 mg/1
Dosage form
Tablet, Film coated
Route
Oral
Labeler
Rising Pharma Holdings, Inc.NDC labeler code 16571
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 204721
Marketing start
Listing expires
Other FDA classes
Cholinergic Muscarinic Antagonists (Mechanism)
Identifiers
Product ID 16571-126_d56e7ced-4633-4325-8e3d-166c84c05886SPL ID d56e7ced-4633-4325-8e3d-166c84c05886SPL set ID b9ba8ad2-27f6-4f18-bd84-73659047910eRxCUI 855178, 855194UNII 5T619TQR3RUPC 0316571126064, 0316571127061
Pharmacologic class
Cholinergic Muscarinic Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N416571012601 followed by a unit qualifier and the quantity

Package 16571-0126-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATIONS AND USAGE Tolterodine tartrate tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 16571-126

What is NDC 16571-126?
16571-126 is the product NDC for Tolterodine Tartrate, Tolterodine tartrate 1 mg/1 tablet, film coated, listed with the FDA by Rising Pharma Holdings, Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Tolterodine Tartrate.
What is the active ingredient?
Tolterodine tartrate.
Who is the labeler?
Rising Pharma Holdings, Inc., NDC labeler code 16571. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Tolterodine Tartrate?
31 other product NDCs are listed under this name. See all Tolterodine Tartrate NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Tolterodine Tartrate NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
Tolterodine TartrateTolterodine tartrate 2 mg/1Capsule, Extended releaseOralMajor Pharmaceuticals0904-757400904-7574-04
Tolterodine TartrateTolterodine tartrate 4 mg/1Capsule, Extended releaseOralMajor Pharmaceuticals0904-757500904-7575-04
Tolterodine tartrateTolterodine tartrate 4 mg/1Capsule, Extended releaseOralUnichem Pharmaceuticals (USA), Inc.29300-30729300-0307-0529300-0307-1329300-0307-19
Tolterodine tartrateTolterodine tartrate 2 mg/1Capsule, Extended releaseOralUnichem Pharmaceuticals (USA), Inc.29300-30629300-0306-0529300-0306-1329300-0306-19
Tolterodine TartrateTolterodine tartrate 2 mg/1Tablet, Film coatedOralCamber Pharmaceuticals, Inc.31722-80631722-0806-0131722-0806-0231722-0806-05+1 more
Tolterodine TartrateTolterodine tartrate 1 mg/1Tablet, Film coatedOralCamber Pharmaceuticals, Inc.31722-80531722-0805-0131722-0805-0231722-0805-05+1 more
Tolterodine TartrateTolterodine tartrate 2 mg/1Capsule, Extended releaseOralSlate Run Pharmaceuticals, LLC70436-16070436-0160-0270436-0160-0470436-0160-06
Tolterodine TartrateTolterodine tartrate 4 mg/1Capsule, Extended releaseOralSlate Run Pharmaceuticals, LLC70436-16170436-0161-0270436-0161-0470436-0161-06
Tolterodine tartrateTolterodine tartrate 2 mg/1Tablet, Film coatedOralMacleods Pharmaceuticals Limited33342-09833342-0098-0933342-0098-1233342-0098-15
Tolterodine tartrateTolterodine tartrate 1 mg/1Tablet, Film coatedOralMacleods Pharmaceuticals Limited33342-09733342-0097-0933342-0097-1233342-0097-15

All 32 Tolterodine Tartrate NDCs

Other NDCs under ANDA 204721

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 204721
ProductStrengthForm · routeLabelerProduct NDC
Tolterodine TartrateTolterodine tartrate 2 mg/1Tablet, Film coatedOralRising Pharma Holdings, Inc.16571-127

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in